WallStreetZenWallStreetZen

NASDAQ: ALVR
Allovir Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Allovir revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ALVR annual revenue was $0.0, with N/A growth year-over-year.

ALVR revenue history

Current Revenue
$0.0
Current Earnings
-$100.2M
Current Profit Margin
0%

Be the first to know when ALVR announces revenue.

ALVR Revenue History By Year

ALVR Yearly RevenueALVR RevenueALVR ChangeALVR Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00-$165.00k-100.00%
2019-12-31$165.00k-$970.00k-85.46%
2018-12-31$1.14MN/AN/A

1 of 1

Allovir Revenue FAQ

What was ALVR's revenue last quarter?

On Invalid Date, Allovir (NASDAQ: ALVR) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Allovir's revenue was $0.00.

What was Allovir's revenue in 2023?

Allovir's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Allovir make in a day?

Based on Allovir annual revenue for the past five years, ALVR makes an average of $90.41 per day.

What was Allovir's annual revenue growth in the past year?

As of Q4 2024, Allovir's revenue has grown null year over year. Allovir's revenue in the past year totaled $0.00.

How much does Allovir make in a year?

Allovir's revenue by year for the past five years is:
  • Allovir's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Allovir's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
  • Allovir's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Allovir's annual revenue for 2020 was $0.00, a 100% decrease from 2019.
  • Allovir's annual revenue for 2019 was $165.00 thousand, a 85.46% decrease from 2018.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.